NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.

Author(s): Guyard A, Boyez A, Pujals A, Robe C, Tran Van Nhieu J, Allory Y, Moroch J, Georges O, Fournet JC, Zafrani ES, Leroy K

Publication: Virchows Arch, 2017, Vol. , Page

PubMed ID: 28812131 PubMed Review Paper? No

Purpose of Paper

This paper investigated the effect of FFPE block storage on DNA yield, amplificability, and integrity as well as on mutation detection and also investigated if the changes were dependent on tissue-type.

Conclusion of Paper

The DNA yield, percentage of amplifiable DNA, maximum amplicon size, ratio of 150 and 300 bp to 75 bp amplicons, and NGS library yield decreased and the number of mutations identified by NGS increased with storage. The decrease in DNA yield was tissue-type dependent with the largest declines noted in colon. 

Studies

  1. Study Purpose

    TThe purpose of this study was to investigate the effect of FFPE block storage on DNA yield, amplificability, and integrity as well as on mutation detection and to investigate if tissue-type is a confounding factor. Colon (21), lung (8), and urothelial tract (17) cancer specimens were fixed in neutral buffered 4% formaldehyde for an unspecified duration and paraffin embedded. DNA was extracted before and after 4-6 years of storage without temperature or humidity control for 4-6 years. Sections were H&E-stained and DNA was extracted using the BioRobot EZ1 with the EZ1 DNA Tissue Kit. While DNA was extracted 4-6 years apart, the same macrodissection area, number and thickness of FFPE sections, and elution volume were used for both extractions and DNA was subsequently stored at -20˚C. DNA yield was determined by fluorometry. The amount of amplifiable DNA was determined by amplification of a 137 bp fragment of KRAS exon 2. The maximum length of amplifiable DNA was determined using theBIOMED2 assay which amplifies 100, 200, 300, 400, 500, and 600 bp amplicons and assessed by electrophoresis. Additionally, a multiplex real-time PCR assay compared amplification of 150 and 300 bp fragments with a 75 bp amplicon. Mutations were detected by NGS using the Ion AmpliSeq Colon and Lung Cancer Panel and by high resolution melting analysis of KRAS exon 2.

    Summary of Findings:

    The DNA yield was decreased for 42 of the 46 blocks after storage (mean of 71 ng/µL versus 32 ng/µL, P<0.0001). However, the decrease in DNA yield with storage was dependent on tissue-type with average decreases of 66% (P<0.001), 38% (P<0.01), and 28% (P<0.05) found for colon, urothelial tract, and lung, respectively (P<0.024). Similarly, the amount of amplifiable DNA decreased from an average of 56% in fresh blocks to 15% for stored blocks (P<0.0001), with decreases from 56% to 15% noted for colon specimens (P<0.0001), 75% to 18% for urothelial specimens (P<0.01), and 26% to 4% for lung specimens (P<0.01). The median percentage of amplifiable DNA that was still amplifiable after storage was comparable among tissue types (9% for colon, 13% for urothelial tract, and 11% for lung). While products of up to 400-600 bp were amplifiable in DNA from fresh blocks, only 200-300 bp fragments were amplifiable in DNA from stored blocks. The ratio of amplified products from fresh blocks of 150 bp and 300 bp relative to 75 bp decreased from 58% and 31%, respectively and decreased from stored blocks to 16% and 2%, respectively (P<0.000, both).

    High resolution melting curves for KRAS exon 2 were comparable in DNA from stored and fresh blocks, regardless of mutational status. However, NGS sequencing of 12 specimens (four of each tissue type) found the mean library yield decreased after block storage by 3.3 fold (0.7 to 17.6-fold, P=0.0108) and that block storage led to a 4.5-fold increase in mutation detection (P=0.006). The authors attribute the increased mutation detection to an increase in C>T and G>A artifacts.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    DNA Fluorometry
    DNA PCR
    DNA SNP assay
    DNA Real-time qPCR
    DNA Next generation sequencing
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 years
    4-6 years
    Biospecimen Acquisition Biospecimen location Colon
    Lung
    Urothelial tract
    SNP assay Specific Technology platform High resolution melting
    Next generation sequencing
    Real-time qPCR Specific Length of gene fragment 75 bp
    150 bp
    300 bp
    PCR Specific Length of gene fragment 100 bp
    200 bp
    300 bp
    400 bp
    500 bp
    600 bp

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...